Cholesterol induces autophagic and apoptotic death in gastric carcinoma cells

International Journal of Oncology

Volumn 44, Issue 3, 2014, Pages 805-811

  Lim, Sung Chul ^a,b   Parajuli, Keshab Raj ^a   Duong, Hong Quan ^a   Choi, Jeong Eun ^a,b   Han, Song I Y ^a,b  

^a Research Center for Resistant Cells   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Apoptosis; Autophagic deagh; Cholesterol; Gastric cancer; Tumor necrosis factor related apoptosis inducing ligand receptor 2

Indexed keywords

CHOLESTEROL; DEATH RECEPTOR 5; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

APOPTOSIS; APOPTOTIC DEATH; ARTICLE; AUTOPHAGIC DEATH; AUTOPHAGY; CANCER CELL CULTURE; CARCINOMA CELL; CELL DEATH; CELL LEVEL; CELL SURVIVAL; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; ENZYME INACTIVATION; GASTRIC CARCINOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; PRIORITY JOURNAL;

APOPTOSIS; AUTOPHAGY; CARCINOMA; CELL SURVIVAL; CHOLESTEROL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84896726439     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2246     Document Type: Article

References (30)

1. Greenlee RT, Hill-Harmon MB, Murray T and Thun M: Cancer statistics, 2001. CA Cancer J Clin 51: 15-36, 2001.
2. Roukos DH: Current status and future perspectives in gastric cancer management. Cancer Treat Rev 26: 243-255, 2000.
3. Fiedorek SC, Malaty HM, Evans DL, Pumphrey CL, Casteel HB, Evans DJ Jr and Graham DY: Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics 88: 578-582, 1991.
4. Plummer M, Franceschi S and Munoz N: Epidemiology of gastric cancer. IARC Sci Publ 2004: 311-326, 2004.
5. Lunet N, Valbuena C, Vieira AL, Lopes C, Lopes C, David L, Carneiro F and Barros H: Fruit and vegetable consumption and gastric cancer by location and histological type: case-control and meta-analysis. Eur J Cancer Prev 16: 312-327, 2007.
6. Kaaks R, Tuyns AJ, Haelterman M and Riboli E: Nutrient intake patterns and gastric cancer risk: a case-control study in Belgium. Int J Cancer 78: 415-420, 1998.
7. Palli D, Russo A and Decarli A: Dietary patterns, nutrient intake and gastric cancer in a high-risk area of Italy. Cancer Causes Control 12: 163-172, 2001.
8. De Stefani E, Correa P, Boffetta P, Deneo-Pellegrini H, Ronco AL and Mendilaharsu M: Dietary patterns and risk of gastric cancer: a case-control study in Uruguay. Gastric Cancer 7: 211-220, 2004.
9. Asano K, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Arima H, Shirota T, Matsumoto T, Iida M and Kiyohara Y: Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: the Hisayama study. Int J Cancer 122: 909-914, 2008.
10. Dessi S, Batetta B, Pulisci D, Spano O, Anchisi C, Tessitore L, Costelli P, Baccino FM, Aroasio E and Pani P: Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer 73: 253-258, 1994.
11. Jafri H, Alsheikh-Ali AA and Karas RH: Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol 55: 2846-2854.
12. Levy RI: Cholesterol and disease - what are the facts? JAMA 248: 2888-2890, 1982.
13. Eichholzer M, Stahelin HB, Gutzwiller F, Ludin E and Bernasconi F: Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study. Am J Clin Nutr 71: 569-574, 2000.
14. Kritchevsky SB and Kritchevsky D: Serum cholesterol and cancer risk: an epidemiologic perspective. Annu Rev Nutr 12: 391-416, 1992.
15. Schatzkin A, Hoover RN, Taylor PR, Ziegler RG, Carter CL, Larson DB and Licitra LM: Serum cholesterol and cancer in the NHANES I epidemiologic follow-up study. National Health and Nutrition Examination Survey. Lancet 2: 298-301, 1987.
16. Tornberg SA, Holm LE, Carstensen JM and Eklund GA: Cancer incidence and cancer mortality in relation to serum cholesterol. J Natl Cancer Inst 81: 1917-1921, 1989.
17. Wannamethee G, Shaper AG, Whincup PH and Walker M: Low serum total cholesterol concentrations and mortality in middle aged British men. BMJ 311: 409-413, 1995.
18. Brunet A, Pages G and Pouyssegur J: Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene 9: 3379-3387, 1994.
19. Edidin M: The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct 32: 257-283, 2003.
20. Zhuang L, Kim J, Adam RM, Solomon KR and Freeman MR: Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest 115: 959-968, 2005.
21. Zhuang L, Lin J, Lu ML, Solomon KR and Freeman MR: Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells. Cancer Res 62: 2227-2231, 2002.
22. Gajate C, Gonzalez-Camacho F and Mollinedo F: Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells. PLoS One 4: e5044, 2009.
23. Mollinedo F and Gajate C: Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy. Drug Resist Updat 9: 51-73, 2006.
24. Iribarren C, Reed DM, Chen R, Yano K and Dwyer JH: Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation 92: 2396-2403, 1995.
25. Kitahara CM, Berrington de Gonzalez A, Freedman ND, Huxley R, Mok Y, Jee SH and Samet JM: Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol 29: 1592-1598.
26. Schuit AJ, Van Dijk CE, Dekker JM, Schouten EG and Kok FJ: Inverse association between serum total cholesterol and cancer mortality in Dutch civil servants. Am J Epidemiol 137: 966-976, 1993.
27. Tornberg SA, Carstensen JM and Holm LE: Risk of stomach cancer in association with serum cholesterol and beta-lipoprotein. Acta Oncol 27: 39-42, 1988.
28. Tabas I: Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 110: 905-911, 2002.
29. Yao PM and Tabas I: Free cholesterol loading of macrophages induces apoptosis involving the fas pathway. J Biol Chem 275: 23807-23813, 2000.
30. Yao PM and Tabas I: Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J Biol Chem 276: 42468-42476, 2001.